StockData
Kazia Therapeutics Ltd logo

Kazia Therapeutics Ltd (KZIA) stock

KZIANasdaqPharmaceutical PreparationsFiscal year ends June 30
Financials through fiscal 2025, year ended Jun 30, 2025Last filing: 20-F on Nov 17, 2026Score 1/30
$5.49+0.18 (+3.39%)

Close on Nov 18, 2026Market cap $8.89MP/E –Yield –

Kazia Therapeutics enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

Kazia Therapeutics's enterprise value was -$39.54M on Nov 11, 2026, against $8.97M a year earlier. Over the last 5 years it ranged from -$40.13M to $79.05M, with a median of $5.29M.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026-$39.54M-904.2%
2025Dec 31, 2025$4.92M+21.9%
2024Dec 31, 2024$4.03M-29.8%
2023Dec 29, 2023$5.75M+32.9%
2022Dec 30, 2022$4.32M-94.5%
2021Dec 31, 2021$79.05M+40.3%
2020Dec 31, 2020$56.36M+166.7%
2019Dec 31, 2019$21.14M+179.6%
2018Dec 31, 2018$7.56M-94.5%
2017Dec 29, 2017$137.47M-39.5%
2016Dec 30, 2016$227.14M–

More Kazia Therapeutics figures

See a number that looks wrong?